Literature DB >> 34864913

Reply to Caldwell et al.

Michael J Satlin1,2, Liang Chen3,4, Claire Douglass5, Michael Hovan5, Emily Davidson6, Rosemary Soave1, Marisa La Spina5, Alexandra Gomez-Arteaga7, Koen van Besien7, Sebastian Mayer7, Adrienne Phillips7, Jing Mei Hsu7, Rianna Malherbe8, Catherine B Small1, Stephen G Jenkins1,2, Lars F Westblade1,2, Barry N Kreiswirth3, Thomas J Walsh1.   

Abstract

Entities:  

Year:  2022        PMID： 34864913      PMCID： PMC9402634          DOI： 10.1093/cid/ciab1001

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


× No keyword cloud information.
  7 in total

1.  Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Authors:  Michael J Satlin; Santosh Vardhana; Rosemary Soave; Tsiporah B Shore; Tomer M Mark; Samantha E Jacobs; Thomas J Walsh; Usama Gergis
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-03       Impact factor: 5.742

2.  Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.

Authors:  Michael Cullen; Neil Steven; Lucinda Billingham; Claire Gaunt; Mark Hastings; Peter Simmonds; Nicholas Stuart; Daniel Rea; Mark Bower; Indrajit Fernando; Robert Huddart; Simon Gollins; Andrew Stanley
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

3.  Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.

Authors:  Giampaolo Bucaneve; Alessandra Micozzi; Francesco Menichetti; Pietro Martino; M Stella Dionisi; Giovanni Martinelli; Bernardino Allione; Domenico D'Antonio; Maurizio Buelli; A Maria Nosari; Daniela Cilloni; Eliana Zuffa; Renato Cantaffa; Giorgina Specchia; Sergio Amadori; Francesco Fabbiano; Giorgio Lambertenghi Deliliers; Francesco Lauria; Robin Foà; Albano Del Favero
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

Review 4.  Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

Authors:  Anat Gafter-Gvili; Abigail Fraser; Mical Paul; Liat Vidal; Theresa A Lawrie; Marianne D van de Wetering; Leontien C M Kremer; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

5.  Causative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated, Central Line-Associated Bloodstream Infections From Oncology Settings, 2009-2012.

Authors:  Isaac See; Alison G Freifeld; Shelley S Magill
Journal:  Clin Infect Dis       Date:  2016-03-01       Impact factor: 9.079

6.  Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.

Authors:  Michael J Satlin; Liang Chen; Claire Douglass; Michael Hovan; Emily Davidson; Rosemary Soave; Marisa La Spina; Alexandra Gomez-Arteaga; Koen van Besien; Sebastian Mayer; Adrienne Phillips; Jing-Mei Hsu; Rianna Malherbe; Catherine B Small; Stephen G Jenkins; Lars F Westblade; Barry N Kreiswirth; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 20.999

7.  Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients.

Authors:  Louise Caldwell; Anjaneya Bapat; Lydia N Drumright; Jonathan Lambourne; Fergus G Jimenez-England; James Aries; Lydia Eccersley; Simon Hallam; Silvia Montoto; Heather Oakervee; John Riches; Samir G Agrawal
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.